Replies to post #23167 on Biotech Values

[St_armands_man]

ENMD - Celgene (CELG)

Interestingly, one of the investors in todays financing with ENMD was Celgene.

P.S. - Dew - I agree with your comment.

[Stock]

ENMD traded 2.40 today for a brief moment. I bought a small number of shares on this dip.

I know they had some news this week. Two years ago, April was a newsworthy month and generated some movement. Last year, April was the top for quite some time in the stock. ASCO in the late spring was not much help last year, either.

I have been reading a little bit, and if I get the gyst of things, the new management is working a bit harder to bring some of the long-promised products out of pre-clinical study and into the world.

I haven't kept up with the stock in a while... 2002/2003 was the last time I payed much serious attention to EntreMed.

Any suggestion that 2006 should be different than 2005? Better or worse than 2004? Any opinions welcomed.